KRISHNA UPPU: Open Payments
NPI 1265567325 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,518 in 70 payments from 16 companies in 2025. Trend: 2023 $171 · 2024 $1,858 · 2025 $2,518
Food & beverage: $2,518
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $582 |
| ABBVIE INC. | 13 | $412 |
| Vanda Pharmaceuticals Inc. | 7 | $283 |
| Otsuka America Pharmaceutical, Inc. | 8 | $237 |
| Neurocrine BioSciences, Inc. | 3 | $190 |
| Axsome Therapeutics, Inc. | 3 | $177 |
| E.R. Squibb & Sons, L.L.C. | 6 | $177 |
| Janssen Pharmaceuticals, Inc | 6 | $120 |
| Lundbeck LLC | 4 | $91 |
| Corcept Therapeutics | 3 | $69 |
Products named: CAPLYTA, VRAYLAR, REXULTI, FANAPT, INGREZZA, Auvelity, COBENFY, SPRAVATO.
Industry payments across FL — which companies pay providers there.
